BELKYRA®
Also known as Deoxycholic acid, this naturally occurring bile acid is an excellent fat-dissolving treatment for those who struggle with a double chin. Injected into targeted areas, it activates an enzyme, leading to destruction of fat cells and reduction in fullness.
​
Full assessment is required prior to treatment as not all submental fullness (double chin) is suitable for Belkyra®.
For optimal results, 2-6 treatments are recommended 6 weeks to 3 months apart.
​
BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/ pain/ swelling/ numbness/ redness/ tingling/ hardness/ itching/ discolouration/ formation of small areas of hardness/ warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years. Allergan, Auckland